Please contact our sales representative to learn more information about this reagents.
Background
Fasinumab is a human monoclonal antibody designed for the treatment of acute sciatic pain. This drug was developed in collaboration by Teva Pharmaceutical Industries and Regeneron Pharmaceuticals.